- Home
- LTRY vs SBFM Comparison
LTRY vs SBFM Comparison
Compare LTRY & SBFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LTRY
- SBFM
- Stock Information
- Founded
- LTRY 2015
- SBFM 2006
- Country
- LTRY United States
- SBFM United States
- Employees
- LTRY N/A
- SBFM N/A
- Industry
- LTRY Computer Software: Prepackaged Software
- SBFM Biotechnology: Pharmaceutical Preparations
- Sector
- LTRY Technology
- SBFM Health Care
- Exchange
- LTRY Nasdaq
- SBFM Nasdaq
- Market Cap
- LTRY N/A
- SBFM 3.7M
- IPO Year
- LTRY N/A
- SBFM N/A
- Fundamental
- Price
- LTRY $0.49
- SBFM $3.14
- Analyst Decision
- LTRY
- SBFM
- Analyst Count
- LTRY 0
- SBFM 0
- Target Price
- LTRY N/A
- SBFM N/A
- AVG Volume (30 Days)
- LTRY 52.0K
- SBFM 90.8K
- Earning Date
- LTRY 11-29-2024
- SBFM 11-11-2024
- Dividend Yield
- LTRY N/A
- SBFM N/A
- EPS Growth
- LTRY N/A
- SBFM N/A
- EPS
- LTRY N/A
- SBFM N/A
- Revenue
- LTRY $5,723,382.00
- SBFM $30,481,982.00
- Revenue This Year
- LTRY N/A
- SBFM $86.70
- Revenue Next Year
- LTRY N/A
- SBFM $126.76
- P/E Ratio
- LTRY N/A
- SBFM N/A
- Revenue Growth
- LTRY 125.44
- SBFM 109.82
- 52 Week Low
- LTRY $0.50
- SBFM $2.42
- 52 Week High
- LTRY $7.01
- SBFM $660.00
- Technical
- Relative Strength Index (RSI)
- LTRY 34.24
- SBFM 52.62
- Support Level
- LTRY $0.51
- SBFM $2.85
- Resistance Level
- LTRY $0.57
- SBFM $3.05
- Average True Range (ATR)
- LTRY 0.03
- SBFM 0.14
- MACD
- LTRY 0.01
- SBFM 0.03
- Stochastic Oscillator
- LTRY 0.00
- SBFM 85.29
About SBFM Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. The company is conducting a proprietary drug development program which is comprised of (i) K1.1 mRNA targeted for liver cancer, (ii) SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections, and (iii) Adva-27a for pancreatic cancer. The company has two reportable segments: Prescription Generic Pharmaceuticals ("Generic Pharmaceuticals") and Nonprescription Over-The-Counter Products ("OTC Products"). The company generates the majority of its revenue from the Generic Pharmaceuticals segment.